Results 321 to 330 of about 832,143 (393)

An encompassing Mendelian randomization study of the causes and consequences of major depressive disorder. [PDF]

Nat Ment Health
Pasman JA, Bergstedt J, Harder A, Gong T, Xiong Y, Hägg S, Fang F, Treur JL, Choi KW, Sullivan PF, Lu Y.   +10 more
europepmc   +1 more source

Olfactory Impairment and Incident Cognitive Decline: A Systematic Review and Meta‐Analysis

International Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background Olfactory impairment (OI) is associated with poor ageing outcomes. While cross‐sectional studies found a high prevalence of OI among patients with neurodegenerative diseases, the temporal relationship remains unclear. This meta‐analysis aims to synthesise the longitudinal association of OI with cognitive decline (CD). Methods PubMed,
Brian Sheng Yep Yeo, Harris Jun Jie Muhammad Danial Song, Benjamin Kye Jyn Tan, Adithya Suresh, Owen Tsung Wen Ho, Jun He Chan, Esther Yanxin Gao, Claire Jing‐Wen Tan, Chong Boon Teo, Christopher Li‐Hsian Chen, Laura Tay, Ecosse L. Lamoureux, Thomas Hummel, Anna See, Shuhui Xu, Song Tar Toh, Tze Choong Charn, Neville Wei Yang Teo   +17 more
wiley   +1 more source

Disease Progression in Multiple System Atrophy: The ASPIRE Multi‐Modal Biomarker Study

Annals of Neurology, EarlyView.
Objective The objective of this study was to characterize changes in candidate biomarkers in early multiple system atrophy (MSA) and identify baseline predictors of faster progression. Methods This 1‐year, multicenter, prospective study assessed clinical, neuroimaging (3T‐magnetic resonance imaging [MRI], dopamine transporter single‐photon emission ...
Margherita Fabbri, Natalia del Campo, Wassilios G. Meissner, Vanessa Rousseau, Agnès Sommet, Pierre Payoux, Pierre Gantet, Amel Drif, Hélène Catalá, Claire Thalamas, Christine Tranchant, Franck Durif, Ana Marques, Alexandre Eusebio, Luc Defebvre, Jean‐Christophe Corvol, Stéphane Thobois, Anthime Flaus, Anne‐Gaelle Corbille, Solène Frismand, Beverley Patterson, Alexandra Foubert‐Samier, Anne Pavy‐Le Traon, Germain Arribarat, Patrice Péran, Olivier Rascol, for the ASPIRE Study Group   +26 more
wiley   +1 more source

Design Considerations for a Phase II Platform Trial in Major Depressive Disorder. [PDF]

Pharm Stat
Freitag MM, Zocholl D, Meyer EL, Gold SM, Roig MB, De Smedt H, Posch M, König F, EU‐PEARL MDD Investigators.   +8 more
europepmc   +1 more source

Persisting Transglutaminase 6 Antibodies in Neurological Gluten‐Related Disorders

Annals of Neurology, EarlyView.
Objective Gluten‐related autoimmunity can cause neurological disease, although the best way to diagnose and monitor such patients is unclear. Serological testing for antibodies against transglutaminase 6 (TG6) has been proposed; however, this is not widely available in clinical practice.
Iain D. Croall, Marios Hadjivassiliou, David S. Sanders, Kevin Teh, Alberto M. Biancardi, Nick Trott, Nigel Hoggard   +6 more
wiley   +1 more source

Sex-stratified genome-wide association meta-analysis of major depressive disorder. [PDF]

Nat Commun
Thomas JT, Thorp JG, Huider F, Grimes PZ, Wang R, Youssef P, Coleman JRI, Byrne EM, Adams M, BIONIC consortium, GLAD Study, Medland SE, Hickie IB, Olsen CM, Whiteman DC, Whalley HC, Penninx BWJH, van Loo HM, Derks EM, Eley TC, Breen G, Boomsma DI, Wray NR, Martin NG, Mitchell BL.   +24 more
europepmc   +1 more source

Associations between Kynurenine pathway metabolites and cognitive dysfunction in major depressive disorder. [PDF]

PLoS One
Pan Y, Xu P, Sun X.
europepmc   +1 more source

Major depressive disorder in multiple sclerosis associated with differences in disease modifying therapy and demographics. [PDF]

Front Neurol
Lee NJ, Hui G, Pike CW, Galetta K, Kipp LB, Dunn J, Le S, Folmsbee SS.   +7 more
europepmc   +1 more source